These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 18298700

  • 41. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.
    Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, CHAMP Investigators.
    N Engl J Med; 2017 Jan 12; 376(2):115-124. PubMed ID: 27788026
    [Abstract] [Full Text] [Related]

  • 42. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.
    Nelles G, Schmitt L, Humbert T, Becker V, Sandow P, Bornhoevd K, Fritzsche D, Schäuble B, TOPMATMIG-0001 investigators.
    J Headache Pain; 2010 Feb 12; 11(1):33-44. PubMed ID: 19894100
    [Abstract] [Full Text] [Related]

  • 43. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2002 Sep 12; 42(8):796-803. PubMed ID: 12390644
    [Abstract] [Full Text] [Related]

  • 44. Cognitive effects of topiramate in migraine patients aged 12 through 17 years.
    Pandina GJ, Ness S, Polverejan E, Yuen E, Eerdekens M, Bilder RM, Ford L.
    Pediatr Neurol; 2010 Mar 12; 42(3):187-95. PubMed ID: 20159428
    [Abstract] [Full Text] [Related]

  • 45. [Effectiveness of topiramate in migraine prophylaxis, an observational study in a consecutive case-serie].
    Gracia-Naya M, Latorre Jiménez A.
    Neurologia; 2005 Jun 12; 20(5):225-31. PubMed ID: 15954031
    [Abstract] [Full Text] [Related]

  • 46. Topiramate for migraine prevention.
    Wenzel RG, Schwarz K, Padiyara RS.
    Pharmacotherapy; 2006 Mar 12; 26(3):375-87. PubMed ID: 16503717
    [Abstract] [Full Text] [Related]

  • 47. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G, Delbrück A, Schulze L, Kademann B, Bornhoevd K, Schäfer S, Schäuble B, TOPMAT-MIG-4009 investigators.
    Headache; 2009 Mar 12; 49(10):1454-65. PubMed ID: 19804392
    [Abstract] [Full Text] [Related]

  • 48. Migraines with and without aura and their response to preventive therapy with topiramate.
    Reuter U, Sanchez Del Rio M, Diener HC, Allais G, Davies B, Gendolla A, Pfeil J, Schwalen S, Schäuble B, van Oene J.
    Cephalalgia; 2010 May 12; 30(5):543-51. PubMed ID: 19732072
    [Abstract] [Full Text] [Related]

  • 49. Topiramate in essential tremor: a double-blind, placebo-controlled trial.
    Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF, Topiramate Essential Tremor Study Investigators.
    Neurology; 2006 Mar 14; 66(5):672-7. PubMed ID: 16436648
    [Abstract] [Full Text] [Related]

  • 50. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ.
    Mayo Clin Proc; 2006 Oct 14; 81(10):1311-9. PubMed ID: 17036556
    [Abstract] [Full Text] [Related]

  • 51. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct 14; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 52. Practical use of topiramate for migraine prevention.
    Brandes JL.
    Headache; 2005 Apr 14; 45 Suppl 1():S66-73. PubMed ID: 15833092
    [Abstract] [Full Text] [Related]

  • 53. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec 14; 40(12):1767-74. PubMed ID: 10612342
    [Abstract] [Full Text] [Related]

  • 54. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD, Ben-Menachem E, Shank RP, Wiegand F.
    Clin Ther; 2005 Feb 14; 27(2):154-65. PubMed ID: 15811478
    [Abstract] [Full Text] [Related]

  • 55. Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.
    Hershey AD, Powers SW, Coffey CS, Eklund DD, Chamberlin LA, Korbee LL, CHAMP Study Group.
    Headache; 2013 May 14; 53(5):799-816. PubMed ID: 23594025
    [Abstract] [Full Text] [Related]

  • 56. Topiramate in the prevention of pediatric migraine: literature review.
    Ferraro D, Di Trapani G.
    J Headache Pain; 2008 Jun 14; 9(3):147-50. PubMed ID: 18385933
    [Abstract] [Full Text] [Related]

  • 57. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK, Schreiber CP, Porter JA, Blumenfeld AM, Farmer KU.
    Headache; 2011 Jan 14; 51(1):21-32. PubMed ID: 21070228
    [Abstract] [Full Text] [Related]

  • 58. Topiramate: a case series study in migraine prophylaxis.
    Young WB, Hopkins MM, Shechter AL, Silberstein SD.
    Cephalalgia; 2002 Oct 14; 22(8):659-63. PubMed ID: 12383061
    [Abstract] [Full Text] [Related]

  • 59. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V, Biondi D, Pfeil J, Schwalen S.
    Headache; 2007 Jan 14; 47(1):13-21. PubMed ID: 17355489
    [Abstract] [Full Text] [Related]

  • 60. Topiramate-induced intractable cough during migraine prophylaxis.
    Maggioni F, Mampreso E, Mainardi F, Lisotto C, Malvindi ML, Zanchin G.
    Headache; 2010 Feb 14; 50(2):301-4. PubMed ID: 19751366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.